Hypercoagulability in acute stroke

To evaluate the clinical significance of hemostatic abnormalities in acute stroke, we studied coagulation and platelet function in 70 patients with recent cerebral infarction or hemorrhage and in 45 age-matched controls. Higher levels of one-stage factor VIII coagulant activity, fibrinopeptide A (FPA), and beta-thromboglobulin were associated with the occurrence of stroke. All hemostatic test results were remarkably similar in patients with ischemic and hemorrhagic stroke. FPA levels and size of the lesion on CT were the only variables independently predicting mortality in a multivariate regression analysis. Our findings demonstrate that hypercoagulability is an important prognostic factor in stroke and lend support to clinical trials of drugs interfering with the coagulation system in the early phase of cerebral ischemia.

[1]  L. Verstraeten,et al.  [The physiology of primary hemostasis]. , 1989, Journal de pharmacie de Belgique.

[2]  A. Morabito.  AMS — A Computer Program for Survival Analysis, General Linear Models and a Stochastic Survival Model , 1986 .

[3]  B. Coull,et al.  Enhanced in vivo platelet activation in subtypes of ischemic stroke. , 1985, Stroke.

[4]  B. Coull,et al.  Prostacyclin infusion in acute cerebral infarction , 1984, Neurology.

[5]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[6]  V. Hachinski,et al.  Early Mortality Following Stroke: A Prospective Review , 1984, Stroke.

[7]  E. Richelson,et al.  Thrombin binding to human brain and spinal cord. , 1983, Mayo Clinic proceedings.

[8]  G. Mulley,et al.  ADP-Induced Platelet Release Reaction in Acute Stroke , 1983, Thrombosis and Haemostasis.

[9]  M. Osawa,et al.  Platelet function tests in thrombotic cerebrovascular disorders. , 1983, Stroke.

[10]  M. Gaweł,et al.  Activation of coagulation and fibrinolytic systems following stroke , 1983, British journal of haematology.

[11]  D. Drachman,et al.  Marker proteins of platelet activation in patients with cerebrovascular disease. , 1982, Archives of neurology.

[12]  Medicine,et al.  Prostaglandin I2, indomethacin, and heparin promote postischemic neuronal recovery in dogs , 1982, Annals of neurology.

[13]  A. Turpie,et al.  Plasma betathromboglobulin and serum fragment E in acute partial stroke , 1982, British journal of haematology.

[14]  P. Mannucci,et al.  Alterations of Factor VIII von Willebrand Factor in Clinical Conditions Associated with an Increase in its Plasma Concentration , 1981, British journal of haematology.

[15]  H. Gralnick,et al.  Influence of factor VIII/von Willebrand factor protein (F VIII/vWF) and F VIII/vWF-poor cryoprecipitate on post-ischemic microvascular reperfusion in the central nervous system. , 1981, Stroke.

[16]  C. Petito,et al.  Platelet Thrombi in Experimental Cerebral Infarction , 1979, Stroke.

[17]  J. Samples,et al.  Platelet Aggregate Ratios – Standardization of Technique and Test Results in Patients with Myocardial Ischemia and Patients with Cerebrovascular Disease , 1977, Thrombosis and Haemostasis.

[18]  J. Couch,et al.  Platelet aggregation, stroke, and transient ischemic attack in middle‐aged and elderly patients , 1976, Neurology.

[19]  M. Raichle,et al.  Blood Coagulation and Plasma Fibrinolytic Enzyme System Pathophysiology in Stroke , 1976, Stroke.

[20]  R. Canfield,et al.  Measurement of fibrinopeptide A in human blood. , 1974, The Journal of clinical investigation.

[21]  F. Mcdowell,et al.  Stroke and Blood Coagulation , 1973, Stroke.

[22]  H. Blumenthal,et al.  A Study of Blood Coagulation Following an Acute Stroke , 1971, Stroke.

[23]  J. Niemetz,et al.  Activated Coagulation Factors: In‐Vivo and in‐Vitro Studies , 1969, British journal of haematology.

[24]  H. Fujishima,et al.  Coagulation studies in cerebrovascular disease , 1967, Neurology.

[25]  R. G. Macfarlane,et al.  Thrombin and the Interaction of Factors VIII and IX , 1965 .